
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-id journal-id-type="publisher-id">IPHB</journal-id><journal-id journal-id-type="publisher-id">iphb20</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32476526</article-id><article-id pub-id-type="pmc">7336992</article-id><article-id pub-id-type="doi">10.1080/13880209.2020.1764058</article-id><article-id pub-id-type="publisher-id">1764058</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Hepatoprotective and antioxidant activities of <italic>Dicranopteris linearis</italic> leaf extract against paracetamol-induced liver intoxication in rats</article-title><alt-title alt-title-type="running-authors">Z. A. Zakaria et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5525-7821</contrib-id><name><surname>Zakaria</surname><given-names>Zainul Amiruddin</given-names></name><xref ref-type="aff" rid="AF0001"><sup>a</sup></xref><xref ref-type="aff" rid="AF0002"><sup>b</sup></xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Kamisan</surname><given-names>Farah Hidayah</given-names></name><xref ref-type="aff" rid="AF0001"><sup>a</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2830-4263</contrib-id><name><surname>Kek</surname><given-names>Teh Lay</given-names></name><xref ref-type="aff" rid="AF0002"><sup>b</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9882-0661</contrib-id><name><surname>Salleh</surname><given-names>Mohd. Zaki</given-names></name><xref ref-type="aff" rid="AF0002"><sup>b</sup></xref></contrib><aff id="AF0001"><label>a</label><institution>Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia</institution>, <country>Malaysia</country>; </aff><aff id="AF0002"><label>b</label><institution>Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA</institution>, Selangor, <country>Malaysia</country></aff></contrib-group><author-notes><corresp id="AN0001">CONTACT Zainul Amiruddin Zakaria <email>zaz@upm.edu.my</email>, <email>drzazakaria@gmail.com</email><institution>Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia</institution>, <addr-line>UPM Serdang</addr-line>, Selangor, 43400, <country>Malaysia</country></corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>6</month><year>2020</year></pub-date><volume>58</volume><issue>1</issue><fpage seq="60">478</fpage><lpage>489</lpage><history><date date-type="received"><day>09</day><month>8</month><year>2019</year></date><date date-type="rev-recd"><day>08</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>18</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IPHB_58_1764058.pdf"/><abstract><title>Abstract</title><p><bold>Context:</bold>
<italic>Dicranopteris linearis</italic> L. (Gleicheniaceae) leaves have been reported to exert hepatoprotective activity.</p><p><bold>Objective:</bold> The hepatoprotective and antioxidant effects of ethyl acetate partition of <italic>D. linearis</italic> (EADL) are investigated.</p><p><bold>Materials and methods:</bold> EADL was subjected to antioxidant and anti-inflammatory studies, and phytochemical analyses. <italic>In vivo</italic> study involved six groups (<italic>n</italic>&#x02009;=&#x02009;6) of overnight fasted Sprague Dawley rats. The test solutions [10% DMSO (normal), 10% DMSO (negative), 200&#x02009;mg/kg silymarin (positive) or EADL (50, 250 or 500&#x02009;mg/kg)] were administered orally once daily for 7 consecutive days followed by oral vehicle (only for normal) or hepatotoxic induction using 3&#x02009;g/kg paracetamol (PCM).</p><p><bold>Results:</bold> EADL exerted &#x02248; 90% radical scavenging effects based on the DPPH and superoxide anion radical scavenging assays, high antioxidant capacity in the oxygen radical absorbance capacity assay (&#x02248; 555,000 units), high total phenolic content (&#x02248; 350&#x02009;mg GAE/100&#x02009;g extract) (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), but low anti-inflammatory effect. EADL also attenuated PCM-induced liver intoxication as indicated by reduced level of serum liver enzymes; increased activity of endogenous enzymatic antioxidant (superoxide dismutase &#x02013; 8.3 vs. 4.0&#x02009;U/g tissue; catalase &#x02013; 119 vs. 52&#x02009;U/g tissue) and; reduced level of lipid peroxidation marker (2.7 vs. 5.0&#x02009;&#x000b5;M). Preliminary screening of EADL revealed the presence of saponins, tannins and flavonoids with further HPLC analysis demonstrating the presence of rutin and quercetin.</p><p><bold>Discussion and conclusion:</bold> EADL exerted hepatoprotective and antioxidant activities; thus, these data support the potential use of <italic>D. linearis</italic> as a new source for future hepatoprotective drug development.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Paracetamol intoxication</kwd><kwd>polyphenolics</kwd><kwd>flavonoids</kwd><kwd>rutin</kwd><kwd>quercetin</kwd></kwd-group><funding-group><award-group><funding-source><named-content content-type="funder-name">Fundamental Research Grant Scheme</named-content></funding-source></award-group><award-group><funding-source><named-content content-type="funder-name">Ministry of Higher Education (MOHE), Malaysia</named-content><named-content content-type="funderidentifier">10.13039/501100003093</named-content></funding-source><award-id>04-01-18-1984FR</award-id></award-group><funding-statement>This research was funded by the Fundamental Research Grant Scheme awarded by the Ministry of Higher Education (MOHE), Malaysia [Reference no.: 04-01-18-1984FR].</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="9"/><page-count count="12"/><word-count count="9720"/></counts></article-meta></front><body><sec id="s0001"><title>Introduction</title><p>Liver disease accounts for approximately 2 million deaths per year worldwide (Asrani et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2019</xref>) and drugs are one potential cause of liver disease. Although drug-induced liver disease is rare, it still represents a serious clinical problem due to its unpredictable nature and potentially fatal course. Drug-induced liver disease accounts for as much as 20% of acute liver failure in paediatric populations and a similar percentage of adults with acute liver failure. Its exact incidence is difficult to document but about 40,000 to 45,000 people may experience a drug-induced liver injury each year (Kirchain and Allen <xref rid="CIT0021" ref-type="bibr">2014</xref>). Through its normally functioning enzymes and processes, the liver often causes a drug to become toxic via a process known as bioactivation.</p><p>One clinically important drug that has been associated with liver injury is paracetamol (PCM). Paracetamol (PCM), (Tylenol<sup>&#x000ae;</sup> in the USA) is the most commonly used over-the-counter analgesic and antipyretic; it can be bought without prescription in most countries despite being the commonest cause of acute liver failure in Western countries (Du et&#x000a0;al. <xref rid="CIT0007" ref-type="bibr">2016</xref>). PCM-induced hepatotoxicity remains the most common cause of acute liver failure in many countries. PCM overdose can cause severe liver injury, liver necrosis (Hinson et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2010</xref>), and kidney damage (Saleem and Iftikhar <xref rid="CIT0036" ref-type="bibr">2019</xref>) in human beings and animals. Given the public concern caused by PCM hepatotoxicity, great efforts have been made to understand the mechanisms of its toxic effects. Many studies indicate that oxidative stress is involved in various PCM associated toxicity including PCM-induced liver disease (Li et al. <xref rid="CIT0026" ref-type="bibr">2015</xref>).</p><p>It is important to briefly highlight that PCM, at therapeutic doses, is metabolised by cytochrome P450 enzymes to form a minor but extremely reactive metabolite known as <italic>N</italic>-acetyl-<italic>p</italic>-benzoquinoneimine (NAPQI), but this metabolite is metabolised and detoxified by glutathione (GSH). However, in PCM overdose, cytochrome P450-catalyzed metabolic activation of PCM generates excessive formation of the reactive NAPQI, which in turn depletes cellular GSH, resulting in a condition known as oxidative stress due to an imbalance between oxidants and antioxidants (Du et&#x000a0;al. <xref rid="CIT0007" ref-type="bibr">2016</xref>). This results in the covalent binding of NAPQI to tissue macromolecules in the biomembrane such as DNA, proteins, carbohydrates and lipids that leads to the oxidation of the lipid components and finally liver injury. Damage to the biomembranes causes several liver enzymes such as ALT, AST, as well as ALP, and molecules such as bilirubin that are initially found in the cytoplasm of hepatocytes to leak into the blood stream. Moreover, since PCM is also metabolised by P450 enzymes in microsomes, it was assumed that P450-mediated metabolism of PCM also generated ROS that contribute to liver damage. The body exhibits protective measures against ROS via enzymes compounds [(e.g., superoxide dismutase (SOD), catalase (CAT), and GSH peroxidase (GSH-Px)], as well as nonenzymatic compounds (e.g., tocopherol/vitamin E, &#x003b2;-carotene, ascorbate, and GSH) (Jafari et&#x000a0;al. <xref rid="CIT0017" ref-type="bibr">2014</xref>). Previous investigations found that the alteration of antioxidant enzyme activities in PCM overdose-induced oxidative stress were associated with a depletion of GSH and an increase of lipid peroxidation, all of which can lead to oxidative stress and finally cell death (Kisaoglu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2014</xref>).</p><p>As such, the United States Food and Drug Administration (USFDA) recommends <italic>N</italic>-acetyl cysteine (NAC), a known antioxidant, as the only therapeutic option for PCM-overdosed patients; however, this medication has its limitations including adverse effects and a narrow therapeutic window (Du et&#x000a0;al. <xref rid="CIT0007" ref-type="bibr">2016</xref>).</p><p>The 21st century has seen a paradigm shift towards therapeutic evaluation of herbal products in liver disease models by carefully synergizing the strengths of the traditional system of medicine with that of the modern concept of evidence-based therapeutic screening, authentication and randomised placebo-controlled clinical trials to support clinical efficacy. In spite of the tremendous advances made, no important and safe hepatoprotective drug is available. Therefore, due importance has been given globally to develop primarily plant-based hepatoprotective medications that are effective against a range of liver disorders (Ilyas et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2016</xref>).</p><p>One of the medicinal plants that have been reported to exert protective effects against PCM-induced liver disease is <italic>Dicranopteris linearis</italic> L. (Gleicheniaceae). Known as &#x02018;<italic>Pokok Resam</italic>&#x02019; in Malay folklore medicine, the leaves of <italic>D. linearis</italic>, have been reported to exert hepatoprotective activity. Earlier studies have shown that the chloroform (Shamsahal Din et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2012</xref>), methanol (Mamat et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2013</xref>) and aqueous (Ismail et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2014</xref>) extracts of <italic>D. linearis</italic> leaves attenuate PCM- as well as carbon tetrachloride (CCl<sub>4</sub>)-induced liver intoxication. Further study using the methanol extract of <italic>D. linearis</italic> leaves (MEDL) also revealed the extract potential to attenuate PCM- and CCl<sub>4</sub>-induced liver intoxication by enhancing the endogenous antioxidant enzymes system (Kamisan et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2014</xref>; Zakaria et&#x000a0;al. <xref rid="CIT0044" ref-type="bibr">2017</xref>).</p><p>Since methanol has the ability to extract polar, non-polar, and intermediate polar bioactive compounds, MEDL might contain a mixture of bioactive compounds that were different in their polarity. The present study was designed to determine the ability of intermediate polar bioactive compounds which exert hepatoprotective activity (McGaw et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2013</xref>). To achieve this, MEDL was sequentially partitioned to obtain the petroleum ether, ethyl acetate and aqueous partitions, which represent partition with polar, intermediate polar or non-polar bioactive compounds. The ethyl acetate partition of MEDL (EADL) was then subjected to PCM-induced hepatotoxicity study in rats.</p></sec><sec id="s0002"><title>Materials and methods</title><sec id="s0003"><title>Sample preparation and preparation of MEDL</title><p>The leaves of <italic>D. linearis</italic> were collected between February and March, 2012 from their natural habitat around Serdang, Selangor, Malaysia. A voucher specimen (SK 1987/11) has been earlier issued by a certified botanist (Dr. Mohd. Shamsul Khamis) and was deposited at the Herbarium of the Institute of Bioscience, Universiti Putra Malaysia (UPM) (Kamisan et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2014</xref>). The leaves were dried for approximately two weeks in an oven at 40&#x02009;&#x000b0;C. The dried leaves were ground to a coarse powder using a mill machine.</p><p>Approximately 160&#x02009;g of powdered leaves were soaked in absolute methanol (ratio of 1:2; w/v) for 72&#x02009;h at room temperature. The extraction process was repeated two more times. The supernatant collected from each extraction was filtered sequentially using a cloth filter, cotton wool, and Whatman No. 1 filter papers and then pooled together before being evaporated under reduced pressure (204 mbar) at 40&#x02009;&#x000b0;C using a vacuum rotary evaporator (Buchi Rotavapor<sup>&#x000ae;</sup> R210/215, Switzerland). The concentrated extract was left to stand in an oven at 30&#x02009;&#x000b0;C to remove traces of methanol until a constant weight of extract was obtained.</p></sec><sec id="s0004"><title>Preparation of EADL</title><p>Approximately 2&#x02009;g of oven-dried MEDL was dissolved in methanol in a separating funnel followed by the addition of distilled water (ratio 1:2; v/v). The mixture was shaken vigorously to enable complete mixture. The mixture was then mixed with 700&#x02009;mL of petroleum ether, shaken vigorously and then left for 2&#x02009;h to settle into two-phase immiscible liquid solutions before the lower phase was collected. These procedures were carried out three times. The collected petroleum ether supernatant was pooled together and then subjected to the evaporation process. The upper layer was mixed with 700&#x02009;mL of ethyl acetate, shaken vigorously and then left for 2&#x02009;h to settle into two-phase immiscible liquid solutions before the lower phase was collected. These procedures were repeated three times. The collected ethyl acetate supernatant was also pooled together and then subjected to the evaporation process. Finally, following the partitioning with ethyl acetate, the remaining residue left was collected as the aqueous partition of MEDL, which was evaporated to remove methanol residue and then kept at &#x02212;80&#x02009;&#x000b0;C for at least 48&#x02009;h before subjected to the freeze-drying process. These partitioning methods were adopted from Ismail Suhaimy et&#x000a0;al. (<xref rid="CIT0016" ref-type="bibr">2017</xref>) with modifications.</p></sec><sec id="s0005"><title>Evaluation of antioxidant activity of EADL</title><sec id="s0006"><title>Total phenolic content (TPC) of EADL</title><p>Total phenolic content (TPC) of EADL was determined using the Folin-Ciocalteu procedure with minor alterations as described by Yahya et&#x000a0;al. (<xref rid="CIT0042" ref-type="bibr">2013</xref>). Briefly, 1&#x02009;mg/mL of methanolic solution of EADL was extracted at room temperature with 1&#x02009;mL of 80% methanol mixed with 1% hydrochloric acid and 1% distilled water on the shaker set at 200&#x02009;rpm for 2&#x02009;h. After that, the mixture was centrifuged at 2817&#x02009;<italic>g</italic> for 15&#x02009;min and the supernatant obtained was decanted into vials. The reaction mixture was later prepared by mixing 200&#x02009;&#x003bc;L of EADL supernatant with 400&#x02009;&#x003bc;L (0.1&#x02009;mL/0.9&#x02009;mL) of Folin-Ciocalteu reagent and allowed the mixture to stand at room temperature for 5&#x02009;min. Then, 400&#x02009;&#x003bc;L sodium bicarbonate (60&#x02009;mg/mL) solution was added and the mixture was again allowed to stand at room temperature for 90&#x02009;min. The absorbance was determined using a spectrophotometer at 725&#x02009;nm. A calibration curve was generated by using the gallic acid (GA) standard optical density, and the levels in the samples were expressed in terms of mg GA equivalent (GAE)/100&#x02009;g extract. Based on the measured absorbance, the concentration of phenolics was read (mg/mL) from the calibration line.</p></sec><sec id="s0007"><title>2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay</title><p>The ability of EADL to induce free radicals scavenging action was determined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay with slight modifications as described by Yahya et&#x000a0;al. (<xref rid="CIT0042" ref-type="bibr">2013</xref>). Approximately 50&#x02009;&#x003bc;L of EADL (1&#x02009;mg/mL) was mixed with 50&#x02009;&#x003bc;L DPPH (FG: 384.32) (1&#x02009;mM in ethanolic solution) and 150&#x02009;&#x003bc;L absolute ethanol (AR grade) in a 96-well microtiter plate in triplicate. The reaction mixture contained test sample ranging in the concentration of 3.13 to 200&#x02009;&#x000b5;g/mL. The 96-well microtiter plate was shaken for 15&#x02009;sec at 500&#x02009;rpm and then left to stand at room temperature for 30&#x02009;min before the absorbance was recorded at 520&#x02009;nm using the Schimadzu UV-Vis 1700 spectrophotometer. The DPPH radical concentration was calculated using the following equation:
<disp-formula id="M0001"><alternatives><graphic xlink:href="IPHB_A_1764058_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d1e541"><mml:mrow><mml:mtext>DPPH</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mtext>scavenging</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mtext>effect</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>%</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>&#x02013;</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow><mml:mi mathvariant="normal">x</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>&#x02013;</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mtext>&#x000a0;&#x000d7;&#x000a0;</mml:mtext><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>
where A<sub>0</sub> is absorbance of negative control, A<sub>1</sub> is the absorbance of positive control (<italic>L</italic>-ascorbic acid) and Axe is the absorbance of sample. The IC<sub>50</sub> was described as the amount of the sample that is sufficient to elicit 50% reduction of the initial DPPH radical concentration. This was calculated from the linear part of the inhibition of DPPH radical (Nithianantham et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2011</xref>). Data analysis was done by using Graph pad PRISM V5.01.</p></sec><sec id="s0008"><title>Superoxide anion radical scavenging assay</title><p>The ability of EADL to induce the superoxide anion radicals scavenging action was measured according to the slightly modified method described by Liu et&#x000a0;al. (<xref rid="CIT0027" ref-type="bibr">1997</xref>). Briefly, the superoxide radicals were produced in phenazine methosulphate-nicotinamide adenine dinucleotide (PMS-NADH) systems via oxidation of NADH and evaluated by the reduction of nitroblue tetrazolium (NBT). In these experiments, the superoxide radicals were produced in 3&#x02009;mL of Tris-HCl buffer (16&#x02009;mM, pH 8) containing 1&#x02009;mL of NBT (50&#x02009;&#x003bc;M), 1&#x02009;mL NADH (78&#x02009;&#x003bc;M) and EADL (25&#x02013;50&#x02009;&#x003bc;g). The reaction was started by adding 1&#x02009;mL of PMS solution (10&#x02009;&#x003bc;M) to the mixture. The reaction mixture was incubated at 25&#x02009;&#x000b0;C for 5&#x02009;min and then the absorbance was read at 560&#x02009;nm using a spectrophotometer (Schimadzu UV-Vis 1700) against blank samples using <italic>L</italic>-ascorbic acid as a positive control. Decreased absorbance of the reaction mixture indicated increasing superoxide anion scavenging activity. The percentage inhibition of superoxide anion production was evaluated using the following formula:
<disp-formula id="M0002"><alternatives><graphic xlink:href="IPHB_A_1764058_M0002.jpg" position="float" orientation="portrait"/><mml:math id="d1e654"><mml:mrow><mml:mtext>Inhibition</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mtext>of</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mtext>superoxide</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mtext>anion</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mtext>generation</mml:mtext><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>%</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>
where A<sub>C</sub> was the absorbance of the control (SOD), and A<sub>T</sub> was the absorbance in the presence of EADL or standard.</p></sec><sec id="s0009"><title>Oxygen radical absorbance capacity (ORAC) test</title><p>The antioxidant capacity of EADL was also determined using the slightly modified oxygen-radical absorbance-capacity (ORAC) assay as described by Huang et&#x000a0;al. (<xref rid="CIT0011" ref-type="bibr">2002</xref>). Briefly, 2,2-azobis (2-amidinopropane) dihydrochloride (AAPH) was dissolved in 10&#x02009;mL of 75&#x02009;mM phosphate buffer (pH 7.4), which was prepared daily as peroxyl-radical generator. A fluorescein stock solution (1&#x02009;mM) was prepared in 75&#x02009;mM phosphate buffer (pH 7.4) and stored in wrapping foil at 5&#x02009;&#x000b0;C. During the analysis, the sodium fluorescein stock solution was diluted 1:100 000 with 75&#x02009;mM phosphate buffer (pH 7.4). The microplate wells were filled with 150&#x02009;&#x003bc;L of working solution of sodium fluorescein and 25&#x02009;&#x003bc;L of Trolox (positive control) dilution in blank wells or with 25&#x02009;&#x003bc;L of EADL (200&#x02009;&#x003bc;g/mL) in sample wells and then was equilibrated by incubating for 10&#x02009;min at 37&#x02009;&#x000b0;C. After the solutions equilibrated, 25&#x02009;&#x003bc;L of 240&#x02009;mM AAPH solution was added to the wells to initiate the reactions. BMG Omega Fluostar Fluorescent Spectrophotometer (BMG LABTECH, Ortenberg, Germany) with injector was used with an excitation filter of 485&#x02009;nm and an emission filter of 520&#x02009;nm. The fluorescence intensity of each well was then measured kinetically with data taken every 1&#x02009;min for 3&#x02009;h. ORAC values were calculated using MARS Data Analysis Reduction Software.</p></sec></sec><sec id="s0010"><title>Evaluation of anti-inflammatory activity of EADL</title><sec id="s0011"><title>Lipoxygenase (LOX) assay</title><p>The lipoxygenase (LOX) assay was carried out using the slightly modified spectrophotometric method as described by Azhar-Ul-Haq et&#x000a0;al. (<xref rid="CIT0002" ref-type="bibr">2004</xref>). Approximately 160&#x02009;&#x003bc;L of sodium phosphate buffer (0.1&#x02009;M, pH 8.0), 10&#x02009;&#x003bc;L of EADL and 20&#x02009;&#x003bc;L of soybean LOX solution were mixed and then incubated for 10&#x02009;min at 25&#x02009;&#x000b0;C. About 10&#x02009;&#x003bc;L of the substrate in the form of sodium linoleic acid solution was added to initiate the reaction. The enzymatic conversion of linoleic acid to form (9Z,11E)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate was followed by the measurement of absorbance change at 234&#x02009;nm over the period of 6&#x02009;min. Reference standards and EADL were dissolved in methanol. All reactions were completed in triplicates in a 96-well microplate.</p></sec><sec id="s0012"><title>Xanthine oxidase (XO) assay</title><p>The spectrophotometric method described by Noro et&#x000a0;al. (<xref rid="CIT0033" ref-type="bibr">1983</xref>) was adopted to measure the xanthine oxidase (XO) inhibiting activity of EADL with slight modifications. Approximately 10&#x02009;&#x003bc;L of the test solution and 10&#x02009;&#x003bc;L of XO solution were mixed with 130&#x02009;&#x003bc;L of potassium phosphate buffer (0.05&#x02009;M, pH 7.5) and incubated for 10&#x02009;min at 25&#x02009;&#x000b0;C. Then 100&#x02009;&#x003bc;L of the substrate in the form of xanthine solution was added to initiate the reaction. The enzymatic conversion of xanthine to form uric acid and hydrogen peroxides was followed by the measurement of absorbance change at 295&#x02009;nm. Reference standard and EADL were dissolved in DMSO. All reactions were completed in triplicates in a 96-well microplate.</p></sec><sec id="s0013"><title>Experimental animals</title><p>Male <italic>Sprague Dawley</italic> rats obtained from the Animal Source Unit, Faculty of Veterinary Medicine (FVM), Universiti Putra Malaysia (UPM), Selangor, Malaysia were used in the hepatoprotective study. The rats (180 to 200&#x02009;g; 8 to 10&#x02009;weeks old) were housed in spacious, hygienic polyethylene cages with wood shaving bedding that were maintained at a constant 27&#x02009;&#x000b1;&#x02009;2&#x02009;&#x000b0;C temperature with 70&#x02013;80% humidity on a standard 12&#x02009;h light/dark cycle in the Animal House Unit, Faculty of Medicine and Health Sciences, UPM, for at least 48&#x02009;h before use. Food and water were available <italic>ad libitum</italic> up to the beginning of the experiments. The animals were handled in compliance with current UPM guidelines for the care of laboratory animals and the ethical guidelines for investigations of experimental pain in conscious animals. The study protocol of the present study was approved by the Animal House and Use Committee, Faculty of Medicine and Health Sciences, UPM (Ethical approval no.: UPM/FPSK/PADS/BR-UUH/00449).</p></sec><sec id="s0014"><title>Hepatoprotective assay</title><p>Rats were divided into six groups with equal number of rats (<italic>n</italic>&#x02009;=&#x02009;6) through random selection and were fasted overnight. Group 1, served as the normal control, was pre-treated orally with vehicle 1 (10% DMSO) for 7&#x02009;days before being treated orally with vehicle 2 (10% DMSO); Group 2, served as the hepatotoxic group, was pre-treated orally with vehicle for 7&#x02009;days followed by the oral administration of 3&#x02009;mg/kg PCM, which was suspended in 10% DMSO; Groups 3, served as the standard drug group, received (oral) 200&#x02009;mg/kg silymarin, which was suspended in 1% carboxymethyl cellulose (CMC). Group 4, 5 and 6 received EADL, in the respective concentration of 50, 250 or 500&#x02009;mg/kg, via oral administration for 7 consecutive days before subjected to the PCM-induced hepatotoxic study. Prior to the administration of test solutions, each group of rats were weighed daily within the period of hepatoprotective study. Each group of rats received the respective dose of test solutions orally once daily for 7 consecutive days. Three hours after the administration of pre-treatment drugs on day 7<sup>th</sup>, Groups 3, 4, 5, 6, 7, 8 and 9 were given PCM. The experimental groups are summarised as in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Experimental design on hepatoprotective effect of EADL against PCM-induced rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Group</th><th align="center">Type of treatment</th><th align="center">Pre-treatment<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th><th align="center">Dose (mg/kg)</th><th align="center">Hepatotoxic inducer<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></th></tr></thead><tbody valign="top"><tr><td align="left">1</td><td align="left">Normal control</td><td align="left">10% DMSO</td><td align="left">&#x02013;</td><td align="left">10% DMSO</td></tr><tr><td align="left">2</td><td align="left">Hepatotoxic control</td><td align="left">10% DMSO</td><td align="left">&#x02013;</td><td align="left">3&#x02009;mg/kg PCM</td></tr><tr><td align="left">3</td><td align="left">Positive control</td><td align="left">Silymarin</td><td align="left">200&#x02009;mg/kg</td><td align="left">3&#x02009;mg/kg PCM</td></tr><tr><td align="left">4</td><td align="left">Treatment</td><td rowspan="3">EADL</td><td align="left">50&#x02009;mg/kg</td><td align="left">3&#x02009;mg/kg PCM</td></tr><tr><td align="left">5</td><td align="left">Treatment</td><td align="left">250&#x02009;mg/kg</td><td align="left">3&#x02009;mg/kg PCM</td></tr><tr><td align="left">6</td><td align="left">Treatment</td><td align="left">500&#x02009;mg/kg</td><td align="left">3&#x02009;mg/kg PCM</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p><sup>a</sup>Administered orally and daily for 7 consecutive days.</p></fn><fn id="TF2"><p><sup>b</sup>Administered orally 3&#x02009;h after the last pre-treatment on 7<sup>th</sup> day.</p></fn><fn id="TF3"><p>All test solutions were administered in the volume of 10&#x02009;ml/kg.</p></fn></table-wrap-foot></table-wrap><p>Forty-eight hours after the administration of PCM, rats from each of the group were anaesthetised using intramuscularly-administered 100&#x02009;mg/kg ketamine and 16&#x02009;mg/kg xylazine. Blood collection was then performed on each rat via cardiac puncture into heparinised bottles and, then, the rats were euthanized by cervical dislocation. Upon euthanization, the liver was instantaneously removed, washed in ice-cold saline to remove blood and duly weighed. A section from the median lobe of the liver was preserved in 10% formalin solution for histological analysis. The remaining liver was quickly frozen in dry ice and stored at &#x02212;80&#x02009;&#x000b0;C for further endogenous antioxidant enzymes analysis.</p></sec><sec id="s0015"><title>Biochemical analysis</title><p>The blood was centrifuged at 3000&#x02009;rpm for 15&#x02009;min to obtain the plasma, which was then aspirated off and frozen at &#x02212;80&#x02009;&#x000b0;C. The plasma samples were later analysed to determine the level of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), and total bilirubin according to standard methods and measured using a Hitachi 902 Automatic Chemical Analyser.</p></sec><sec id="s0016"><title>Determination of antioxidant enzymes level and MDA level in liver homogenates</title><p>A 10% (w/v) homogenate, obtained from homogenisation of liver tissue in cold phosphate buffer (5&#x02009;mM, pH 7.4), was centrifuged at 4000&#x02009;rpm for 15&#x02009;min at 4&#x02009;&#x000b0;C. Protein concentration was determined using the Bradford method as described by Lowry et&#x000a0;al. (<xref rid="CIT0028" ref-type="bibr">1951</xref>) with bovine serum albumin (BSA) used as a standard. Then, the supernatant of liver homogenate was subjected to the estimation of SOD and CAT activity and MDA level using the commercial kits according to the respective manufacturer&#x02019;s instructions (Superoxide Dismutase Assay Kit, Catalase Assay Kit and TBARS Assay Kit, Cayman Chemical Company, Ann Arbor, MI, USA).</p></sec><sec id="s0017"><title>Histopathological analysis of PCM-intoxicated liver tissue</title><p>The livers were regularly processed using the Automatic Tissue Processor (Leica TP1020, Germany), and then embedded in paraffin wax with Leica EG 1160 (Leica Microsystems, Germany). Each tissue was sectioned to a thickness between 5 to 6&#x02009;&#x000b5;m using a microtome (Leica RM2125 RTS, Singapore) and then stained with haematoxylin and eosin dye using the Tissue-Tek Prisma-Ezs Autostainer (Sakura, Torrance, CA, USA) for microscopic observation of histopathological changes in the livers. The microscopic observation was done by using light microscope Olymphus-CX31 (Olympus, Japan). The liver sections were then scored and evaluated by pathologist according to the severity of the hepatic injury as described by El-Beshbishy et&#x000a0;al. (<xref rid="CIT0008" ref-type="bibr">2010</xref>) with modifications.</p></sec><sec id="s0018"><title>Phytochemical screening of EADL</title><p>EADL was investigated by qualitative tests for saponins, steroids, flavonoids, triterpenes, tannins and alkaloids according to the detailed procedures described by Ikhiri et&#x000a0;al. (<xref rid="CIT0013" ref-type="bibr">1992</xref>).</p></sec><sec id="s0019"><title>High performance liquid chromatography (HPLC) analysis of EADL</title><p>EADL was subjected to HPLC analysis using the following HPLC system; Waters Delta 600 with 600 Controller equipped with Waters 996 photodiode array detector and a Phenomenex Luna column (5&#x02009;&#x000b5;m; 4.6&#x02009;mm i.d.&#x02009;&#x000d7;&#x02009;250&#x02009;mm) (Torrance, CA, USA). The procedures used were as reported by Kamisan et&#x000a0;al. (<xref rid="CIT0019" ref-type="bibr">2014</xref>). In brief, two types of eluants, namely, 0.1% aqueous formic acid (eluant A) and acetonitrile (eluant B) were used. The gradient elution was programmed with the initial condition of 95% A and 5% B (acetonitrile) with a linear gradient reaching 25% B at <italic>t</italic>&#x02009;=&#x02009;12&#x02009;min. After 10&#x02009;min (<italic>t</italic>&#x02009;=&#x02009;22&#x02009;min), gradient of B was decreased to 15% and sustained for 12&#x02009;min (<italic>t</italic>&#x02009;=&#x02009;30&#x02009;min). Starting from <italic>t</italic>&#x02009;=&#x02009;30&#x02009;min, the programme was returned to the initial solvent composition at <italic>t</italic>&#x02009;=&#x02009;35&#x02009;min. Millennium 32 Chromatography Software (Waters Co., Milford, MA, USA) was used to record and integrate the chromatograms at peak areas with the peak elution monitored at various wavelengths, namely 210, 254, 280, 300, 330 and 366&#x02009;nm. The verified chromatograms were analysed and the recorded retention times, peak areas and UV spectra of main peaks were studied. The HPLC profile of EADL was also analysed by comparing the chromatogram of EADL against the respective chromatograms of several pure bioactive compounds available in the laboratory, namely fisetin, quercetin rutin, quercitrin, naringenin, genistein, pinostrobin, hesperetin, flavanone, 4&#x02032;,5,7-trihydroxyflavanone, 2,4,4&#x02032;-trihydroxychalcone, dihydroquercetin, or hesperetin at 254&#x02009;nm. These bioactive compounds were earlier purchased from the Sigma Aldrich Co. (St. Louis, MO, USA). Retention times and the UV spectrums for each of the peak of standard pure compounds were compared against the peaks of EADL and, the similarity indicate the presence of the specific bioactive compounds.</p></sec></sec><sec id="s0020"><title>Statistical analysis</title><p>Data were expressed as mean values&#x02009;&#x000b1;&#x02009;SD of six rats in each group. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Dunnet&#x02019;s Multiple Comparison test with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 being considered statistically significant. Statistical analysis was conducted with Graph Pad Prism software version 5.</p></sec></sec><sec id="s0021"><title>Results</title><sec id="s0022"><title>Extraction yield of EADL</title><p>Approximately 74.00&#x02009;g of MEDL were partitioned to yield 3.38&#x02009;g of PEDL, 8.59&#x02009;g of EADL and 11.27&#x02009;g of AQDL. EADL was further tested for antioxidant, anti-inflammatory, and hepatoprotective activities.</p></sec><sec id="s0023"><title>Antioxidant activity of EADL</title><sec id="s0024"><title>TPC value of EADL</title><p>The TPC value of EADL recorded after colorimetric analysis was approximately 352.18&#x02009;&#x000b1;&#x02009;48.40&#x02009;mg GAE/100&#x02009;g extract (<xref rid="t0002" ref-type="table">Table 2</xref>). This finding indicates that EADL contained a high TPC value and corresponds with the standard requirement that any compounds with TPC value greater than 100&#x02009;mg GAE/100&#x02009;mg extract is considered to have a high TPC value.</p><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>TPC value, free radical scavenging activity and antioxidant capacity of EADL.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Sample</th><th rowspan="2" align="center">Concentration (&#x000b5;g/ml)</th><th rowspan="2" align="center">Standard drug</th><th rowspan="2" align="center">TPC value (mg GAE/1&#x02009;g dry weight of extract)<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></th><th colspan="2" align="center">Free radical scavenging activity<hr/></th><th align="center">Antioxidant capacity</th></tr><tr><th align="center">DPPH (% AA)</th><th align="center">SOA (% AA)</th><th align="center">ORAC<xref ref-type="table-fn" rid="TF7"><sup>b</sup></xref> (mmol TE/1&#x02009;g dry weight of extract)</th></tr></thead><tbody valign="top"><tr><td rowspan="4">EADL</td><td rowspan="4" align="char" char=".">200</td><td align="left">Gallic acid</td><td align="left">352.2&#x02009;&#x000b1;&#x02009;48.4</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td rowspan="2">Ascorbic acid</td><td align="center">&#x02013;</td><td align="center">93.7&#x02009;&#x000b1;&#x02009;3.0</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="char" char=".">92.6&#x02009;&#x000b1;&#x02009;2.2</td><td align="center">&#x02013;</td></tr><tr><td align="left">Trolox</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="char" char=".">555&#x02009;&#x000b1;&#x02009;12.7</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p>All values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM.</p></fn><fn id="TF5"><p>% AA refers to percentage of antioxidant potential.</p></fn><fn id="TF6"><p><sup>a</sup>Data, expressed as TPC mg GAE/1&#x02009;g dry weight of extract, were mean values of triplicate wells in duplicate experiments., Standard error of mean (SEM) &#x0003c; 5%.</p></fn><fn id="TF7"><p><sup>b</sup>Data, expressed as ORAC value mmol Trolox Equivalent (TE)/1&#x02009;g dry weight of extract, were mean values of triplicate wells in duplicate experiments, standard error mean (SEM) &#x0003c; 30%.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0025"><title>Effect of EADL against the DPPH- and SOA-radical scavenging activities, and ORAC value</title><p>Effect of EADL against the DPPH radical scavenging assay is depicted in <xref rid="t0002" ref-type="table">Table 2</xref>. At the concentration of 200&#x02009;&#x000b5;g/mL, EADL caused a 94% radical scavenging activity when compared to the standard drug, 200&#x02009;&#x000b5;g/mL ascorbic acid. The IC<sub>50</sub> value recorded for EADL was 76&#x02009;&#x000b5;g/mL.</p><p>Effect of EADL against the SOA radical scavenging assay is also shown in <xref rid="t0002" ref-type="table">Table 2</xref>. At the concentration of 200&#x02009;&#x000b5;g/mL, EADL caused 93% radical scavenging activity when compared to the standard drug, 200&#x02009;&#x000b5;g/mL ascorbic acid.</p><p>In addition, the antioxidant capacity of EADL measured using the ORAC assay is also demonstrated in <xref rid="t0002" ref-type="table">Table 2</xref>. At the concentration of 200&#x02009;&#x000b5;g/mL, EADL was found to produce approximately 555&#x02009;mmol Trolox Equivalent (TE)/1&#x02009;g dry weight of extract.</p></sec></sec><sec id="s0026"><title><italic>In vitro</italic> anti- inflammatory activity of EADL</title><sec id="s0027"><title>Effect of EADL against the LOX- and XO-mediated inflammatory assays</title><p>Effect of EADL on <italic>in&#x000a0;vitro</italic> LOX- and XO-mediated inflammatory assay is shown in <xref rid="t0003" ref-type="table">Table 3</xref>. At the concentration of 100&#x02009;&#x000b5;g/mL, EADL induced a low inhibitory effect against both inflammatory enzymes activity with the recorded value of approximately 26% and 1.5%, respectively.</p><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Effect of EADL on <italic>in&#x000a0;vitro</italic> inflammatory activity mediated by LOX and XO.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Sample</th><th rowspan="2" align="center">Concentration (&#x000b5;g/ml)</th><th colspan="2" align="center">Inhibition of Inflammation (%)<hr/></th></tr><tr><th align="center">LOX activity</th><th align="center">XO activity</th></tr></thead><tbody valign="top"><tr><td align="left">EADL</td><td align="center">100</td><td align="center">25.9&#x02009;&#x000b1;&#x02009;4.4</td><td align="center">1.5&#x02009;&#x000b1;&#x02009;0.2</td></tr></tbody></table><table-wrap-foot><fn id="TF8"><p>All values are expressed as mean&#x02009;&#x000b1;&#x02009;SEM.</p></fn><fn id="TF9"><p>Note: H, high (71&#x02013;100%); M, moderate (41&#x02013;70%); L, low (0&#x02013;40%); NA, not active (Ismail Suhaimy et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2017</xref>).</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s0028"><title><italic>In vivo</italic> hepatoprotective activity of EADL against PCM-induced intoxication</title><sec id="s0029"><title>Effect of EADL pre-treatment on the PCM-intoxicated rat body weight (BW), liver weight (LW) and their ratio (LW/BW)</title><p><xref rid="t0004" ref-type="table">Table 4</xref> shows the effect of EADL pre-treatment on body weight (BW), liver weight (LW) and their ratio (LW/BW) in PCM-intoxicated rats. Rats from PCM-induced hepatotoxic control group (Group 2) showed a significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increase in the LW when compared with the normal control group (Group 1). Pre-treatment with EADL, at all concentrations, significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) decreased the LW when compared to the PCM-intoxicated group. Interestingly, pre-treatment with EADL as well as 200&#x02009;mg/kg silymarin also caused significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduction in the LW/BW ratio, thus, indicating their ability to attenuate PCM-induced liver damage.</p><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Effect of EADL pre-treatment on the body weight (BW), liver weight (LW) and their ratio (LW/BW) in PCM intoxicated rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Group</th><th align="center">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">Body weight (BW) (g)</th><th align="center">Liver weight (LW) (g)</th><th align="center">LW/BW (%)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal Control</td><td align="center">Control</td><td align="center">&#x02013;</td><td align="char" char=".">208.7&#x02009;&#x000b1;&#x02009;5.6</td><td align="char" char=".">5.9&#x02009;&#x000b1;&#x02009;0.3</td><td align="char" char=".">2.8&#x02009;&#x000b1;&#x02009;0.1</td></tr><tr><td align="left">Negative Control</td><td align="center">DMSO&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF11">*</xref></td><td align="center">&#x02013;</td><td align="char" char=".">219.5&#x02009;&#x000b1;&#x02009;4.7</td><td align="char" char=".">9.7&#x02009;&#x000b1;&#x02009;0.9<xref ref-type="table-fn" rid="TF12"><sup>a</sup></xref></td><td align="char" char=".">4.4&#x02009;&#x000b1;&#x02009;0.4<xref ref-type="table-fn" rid="TF12"><sup>a</sup></xref></td></tr><tr><td align="left">Positive Control</td><td align="center">Silymarin&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF11">*</xref></td><td align="center">200</td><td align="char" char=".">209.4&#x02009;&#x000b1;&#x02009;4.7</td><td align="char" char=".">6.9&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td><td align="char" char=".">3.3&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td></tr><tr><td rowspan="3">Treatment</td><td rowspan="3">EADL&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF11">*</xref></td><td align="center">50</td><td align="char" char=".">215.7&#x02009;&#x000b1;&#x02009;6.6</td><td align="char" char=".">7.1&#x02009;&#x000b1;&#x02009;0.5<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td><td align="char" char=".">3.3&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td></tr><tr><td align="center">250</td><td align="char" char=".">219.8&#x02009;&#x000b1;&#x02009;7.1</td><td align="char" char=".">7.8&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td><td align="char" char=".">3.6&#x02009;&#x000b1;&#x02009;0.4<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td></tr><tr><td align="center">500</td><td align="char" char=".">217.5&#x02009;&#x000b1;&#x02009;4.7</td><td align="char" char=".">6.2&#x02009;&#x000b1;&#x02009;0.4<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td><td align="char" char=".">2.9&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF13"><sup>b</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF10"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF11"><p>*PCM was administered in the dose of 3&#x02009;mg/kg.</p></fn><fn id="TF12"><p><sup>a</sup>Significant different as compared to normal control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF13"><p><sup>b</sup>Significant different as compared to negative control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0030"><title>Effect of EADL pre-treatment on the serum biochemical parameters (ALT, AST, ALP and TB) in PCM-intoxicated rats</title><p><xref rid="t0005" ref-type="table">Table 5</xref> depicts the effect of EADL pre-treatment on serum liver biochemical parameters, namely ALT, AST, ALP and TB, in PCM-intoxicated rats. Liver damage induced by PCM (Group 2) caused significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increased in serum liver marker enzymes (i.e., ALT, AST and ALP), and TB levels when compared to the normal control group (Group 1), which suggested that there was leakages of the said enzymes and TB into the blood circulation resulting from the liver damaged. Pre-treatment with EADL, at all concentrations, caused significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduction in PCM-induced increase levels of ALT, AST, ALP and TB. This reversal against PCM-induced effects was also seen with silymarin (Group 3).</p><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5.</label><caption><p>Effect of EADL pre-treatment on the levels of ALT, AST, ALP, and TB in PCM intoxicated rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Group</th><th align="center">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">ALT (U/L)</th><th align="center">AST (U/L)</th><th align="center">ALP (U/L)</th><th align="center">TB (umol/L)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal control</td><td align="center">Control</td><td align="center">&#x02013;</td><td align="char" char=".">15.8&#x02009;&#x000b1;&#x02009;2.9</td><td align="char" char=".">95.1&#x02009;&#x000b1;&#x02009;5.9</td><td align="char" char=".">115.7&#x02009;&#x000b1;&#x02009;7.0</td><td align="char" char=".">0.5&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td align="left">Negative control</td><td align="center">DMSO&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF15">*</xref></td><td align="center">&#x02013;</td><td align="char" char=".">1714.3&#x02009;&#x000b1;&#x02009;142.2<xref ref-type="table-fn" rid="TF16"><sup>a</sup></xref></td><td align="char" char=".">2266.2&#x02009;&#x000b1;&#x02009;340.4<xref ref-type="table-fn" rid="TF16"><sup>a</sup></xref></td><td align="char" char=".">330.0&#x02009;&#x000b1;&#x02009;42.4<xref ref-type="table-fn" rid="TF16"><sup>a</sup></xref></td><td align="char" char=".">4.1&#x02009;&#x000b1;&#x02009;0.8<xref ref-type="table-fn" rid="TF16"><sup>a</sup></xref></td></tr><tr><td align="left">Positive control</td><td align="center">Silymarin&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF15">*</xref></td><td align="center">200</td><td align="char" char=".">474.5&#x02009;&#x000b1;&#x02009;82.2<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">690.9&#x02009;&#x000b1;&#x02009;146.6<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">195.5&#x02009;&#x000b1;&#x02009;11.1<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">2.3&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td></tr><tr><td rowspan="3">Treatment</td><td rowspan="3">EADL&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF15">*</xref></td><td align="center">50</td><td align="char" char=".">1024.4&#x02009;&#x000b1;&#x02009;230.1<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">971.7&#x02009;&#x000b1;&#x02009;226.1<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">377.8&#x02009;&#x000b1;&#x02009;53.7</td><td align="char" char=".">1.1&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td></tr><tr><td align="center">250</td><td align="char" char=".">608.9&#x02009;&#x000b1;&#x02009;340.0<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">800.8&#x02009;&#x000b1;&#x02009;291.0<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">225.0&#x02009;&#x000b1;&#x02009;10.0<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">1.3&#x02009;&#x000b1;&#x02009;0.4<sup>b</sup></td></tr><tr><td align="center">500</td><td align="char" char=".">108.7&#x02009;&#x000b1;&#x02009;29.0<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">313.0&#x02009;&#x000b1;&#x02009;66.0<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">198.5&#x02009;&#x000b1;&#x02009;19.8<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td><td align="char" char=".">1.5&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF17"><sup>b</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF14"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF15"><p>*PCM was administered in the dose of 3&#x02009;mg/kg.</p></fn><fn id="TF16"><p><sup>a</sup>Significant different as compared to normal control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF17"><p><sup>b</sup>Significant different as compared to negative control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0031"><title>Effects of EADL pre-treatment on the activities of endogenous antioxidant enzymes defence (i.e., CAT and SOD) and the level of end product of lipid peroxidation (i.e., MDA)</title><p>Effect of EADL on the activities of several endogenous antioxidant enzymes defence namely CAT and SOD, is shown in <xref rid="t0006" ref-type="table">Table 6</xref>. In the PCM-induced hepatotoxic group (Group 2), a significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) decreased in the liver CAT and SOD activities was observed in comparison to the normal control group. However, pre-treatment with silymarin or EADL, at the doses of 250 and 500&#x02009;mg/kg, was found to reverse the toxic effect of PCM by causing a significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increase in the activities of liver&#x02019;s CAT and SOD when compared to the PCM-intoxicated group (Group 2) indicating the ability of EADL to trigger hepatoprotective activity partly via the activation of endogenous enzymatic antioxidant system.</p><table-wrap id="t0006" orientation="portrait" position="float"><label>Table 6.</label><caption><p>Effect of EADL pre-treatment on the levels of SOD, CAT and MDA in liver of PCM intoxicated rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Group</th><th align="center">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">CAT (U/g tissue)</th><th align="center">SOD (U/g tissue)</th><th align="center">MDA (&#x000b5;M)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal control</td><td align="center">DMSO&#x02009;+&#x02009;DMSO</td><td align="center">&#x02013;</td><td align="char" char=".">114.8&#x02009;&#x000b1;&#x02009;1.6</td><td align="char" char=".">9.7&#x02009;&#x000b1;&#x02009;0.4</td><td align="char" char=".">2.6&#x02009;&#x000b1;&#x02009;0.6</td></tr><tr><td align="left">Negative control</td><td align="center">DMSO&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF19">*</xref></td><td align="center">&#x02013;</td><td align="char" char=".">92.9&#x02009;&#x000b1;&#x02009;1.9<xref ref-type="table-fn" rid="TF20"><sup>a</sup></xref></td><td align="char" char=".">4.0&#x02009;&#x000b1;&#x02009;0.1<xref ref-type="table-fn" rid="TF20"><sup>a</sup></xref></td><td align="char" char=".">5.0&#x02009;&#x000b1;&#x02009;0.6<xref ref-type="table-fn" rid="TF20"><sup>a</sup></xref></td></tr><tr><td align="left">Positive control</td><td align="center">Silymarin&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF19">*</xref></td><td align="center">200</td><td align="char" char=".">109.5&#x02009;&#x000b1;&#x02009;4.6<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td><td align="char" char=".">11.8&#x02009;&#x000b1;&#x02009;1.5</td><td align="char" char=".">2.6&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td></tr><tr><td rowspan="3">Treatment</td><td rowspan="3">EADL&#x02009;+&#x02009;PCM<xref ref-type="table-fn" rid="TF19">*</xref></td><td align="center">50</td><td align="char" char=".">96.9&#x02009;&#x000b1;&#x02009;2.7</td><td align="char" char=".">5.3&#x02009;&#x000b1;&#x02009;0.9</td><td align="char" char=".">2.6&#x02009;&#x000b1;&#x02009;0.7<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td></tr><tr><td align="center">250</td><td align="char" char=".">112.7&#x02009;&#x000b1;&#x02009;5.7<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td><td align="char" char=".">7.9&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td><td align="char" char=".">3.0&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td></tr><tr><td align="center">500</td><td align="char" char=".">115.2&#x02009;&#x000b1;&#x02009;3.4<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td><td align="char" char=".">8.3&#x02009;&#x000b1;&#x02009;0.5<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td><td align="char" char=".">2.7&#x02009;&#x000b1;&#x02009;0.7<xref ref-type="table-fn" rid="TF21"><sup>b</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF18"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF19"><p>*PCM was administered in the dose of 3&#x02009;mg/kg.</p></fn><fn id="TF20"><p><sup>a</sup>Significant different as compared to normal control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF21"><p><sup>b</sup>Significant different as compared to negative control (DMSO&#x02009;+&#x02009;PCM), <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn></table-wrap-foot></table-wrap><p><xref rid="t0006" ref-type="table">Table 6</xref> also shows the effect of EADL pre-treatment on the level of end product of lipid peroxidation, namely MDA. Level of MDA in the liver of PCM intoxicated rats (Group 2) was significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) elevated in comparison to the normal control group (Group 1). Silymarin and all doses of EADL significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduced the toxic effect of PCM by reversing and restoring the level of MDA towards its normal value when compared to the PCM-intoxicated group (Group 2) indicating that EADL induced hepatoprotective activity partly via the attenuation of lipid peroxidation.</p></sec><sec id="s0032"><title>Histopathological findings on the PCM-induced hepatotoxic liver with or without EADL pre-treatment</title><p>Effect of EADL pre-treatment on the PCM-intoxicated liver histopathology is presented in <xref ref-type="fig" rid="F0001">Figure 1</xref>. Histopathological observations of liver sections from the normal control group (Group 1) showed normal cellular architecture with distinct hepatic cells, sinusoidal spaces and a central vein (<xref ref-type="fig" rid="F0001">Figure 1(a)</xref>). In contrast, the PCM- intoxicated group (Group 2) exhibited the most severe damage of cellular architecture with massive necrosis, ballooning degeneration, broad infiltration of lymphocytes, and the loss of cellular boundaries observed (<xref ref-type="fig" rid="F0001">Figure 1(b)</xref>). Pre-treatment with 200&#x02009;mg/kg silymarin (Group 3) reversed the effect of PCM intoxication on the liver indicated by changes that almost improved the cellular architecture such as the presence of only patches of necrotic hepatocytes (<xref ref-type="fig" rid="F0001">Figure 1(c)</xref>). On the other hand, pre-treatment with EADL, at the doses of 50, 250, and 500&#x02009;mg/kg, caused a relatively normal lobular pattern with a mild degree of necrosis and lymphocyte infiltration when compared to the PCM-intoxicated group (<xref ref-type="fig" rid="F0001">Figure 1(d&#x02013;f)</xref>). The histological scoring of those changes is provided in <xref rid="t0007" ref-type="table">Table 7</xref>.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>(a) Normal liver tissue, b) PCM intoxicated liver tissue (negative control) showed large area of haemorrhagic necrosis around centrilobular region, and inflammatory cell infiltration at the centre of the necrotic foci, c) Effect of 200&#x02009;mg/kg silymarin pre-treatment on PCM intoxicated liver tissue showing preservation of normal hepatocytes, d) Effect of 50&#x02009;mg/kg EADL pre-treatment on PCM intoxicated liver tissue showing mild sinusoidal congestion and cellular swelling, e) Effect of 250&#x02009;mg/kg EADL pre-treatment on PCM intoxicated liver tissue showing moderate haemorrhagic necrosis in centrilobular region and presence of inflammatory infiltrate, f) Effect of 500&#x02009;mg/kg EADL pre-treatment on PCM intoxicated liver tissue showing mild inflammatory infiltrate and mild cellular swelling. (H&#x00026;E staining, 100x magnification). CV) Central vein. IF) Inflammatory infiltrate. HN) Haemorrhagic necrosis. SC) Sinusoidal congestion.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1764058_F0001_C"/></fig><table-wrap id="t0007" orientation="portrait" position="float"><label>Table 7.</label><caption><p>Histopathological scoring of the liver section of PCM intoxicated rats with or without EADL pre-treatment.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">Steatosis</th><th align="center">Necrosis</th><th align="center">Inflammation</th><th align="center">Hemorrhage</th></tr></thead><tbody valign="top"><tr><td align="left">Control</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td align="left">DMSO&#x02009;+&#x02009;PCM</td><td align="center">&#x000a0;</td><td align="center">+</td><td align="center">+++</td><td align="center">++</td><td align="center">+</td></tr><tr><td align="left">Silymarin&#x02009;+&#x02009;PCM</td><td align="center">200</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td rowspan="3">EADL&#x02009;+&#x02009;PCM</td><td align="center">50</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td align="center">250</td><td align="center">+</td><td align="center">++</td><td align="center">+</td><td align="center">&#x02212;</td></tr><tr><td align="center">500</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr></tbody></table><table-wrap-foot><fn id="TF22"><p>The severity of various features of hepatic injury was evaluated based on those following scoring scheme:</p></fn><fn id="TF23"><p>&#x02212; normal; + mild effect; ++ moderate effect; +++ severe effect.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s0033"><title>Phytochemicals content of EADL</title><p>Following the qualitative phytochemical screening of EADL, several classes of bioactive compounds, namely saponins, flavonoids, tannins and polyphenolic compounds and steroids were detected in EADL (<xref rid="t0008" ref-type="table">Table 8</xref>).</p><table-wrap id="t0008" orientation="portrait" position="float"><label>Table 8.</label><caption><p>Comparison on the presence of phytochemical constituents in different partitions of MEDL.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Sample</th><th colspan="6" align="center">Phytochemical constituents<hr/></th><th rowspan="2" align="center">Conclusion</th></tr><tr><th align="center">Alkaloids</th><th align="center">Saponins</th><th align="center">Flavonoids</th><th align="center">Tannins and Polyphenolic compound</th><th align="center">Triterpenes</th><th align="center">Steroids</th></tr></thead><tbody valign="top"><tr><td align="left">PEDL</td><td align="center">&#x02212;</td><td align="center">1+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">1+</td><td align="left">Saponins and steroids only presence.</td></tr><tr><td align="left">EADL</td><td align="center">&#x02212;</td><td align="center">3+</td><td align="center">1+</td><td align="center">2+</td><td align="center">&#x02212;</td><td align="center">2+</td><td align="left">Saponins, flavonoids, tannins and polyphenolic compound and steroids presence.</td></tr><tr><td align="left">AQDL</td><td align="center">&#x02212;</td><td align="center">1+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">1+</td><td align="center">&#x02212;</td><td align="left">Saponins and triterpenes only presence.</td></tr></tbody></table></table-wrap></sec><sec id="s0034"><title>HPLC profile of AQDL</title><p><xref ref-type="fig" rid="F0002">Figure 2(a)</xref> shows the HPLC profiles of EADL determined at 210, 254, 280, 300, 330, and 366&#x02009;nm. From the chromatograms obtained, various peaks were detected at different wavelengths. Of these, only six major peaks were constantly detected at all wavelengths with the recorded retention time (R<sub>T</sub>) of 19.3 (Peak 1), 19.9 (Peak 2), 20.8 (Peak 3), 22.7 (Peak 4), 23.1 (Peak 5) and 26.8 (Peak 6) min (<xref ref-type="fig" rid="F0002">Figure 2(b)</xref>).</p><fig-group id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>(a) HPLC profile of EADL determined as various wavelength (210&#x02013;366&#x02009;nm). (b) HPLC chromatogram of EADL. Various peaks were detected at different wavelengths with some of them found to possess UV-vis spectral that is a characteristic of flavonoid-based bioactive compound, namely peaks with a retention time (R<sub>T</sub>) of 19.3, 19.9, 20.8, 22.7, 23.1 and 26.8&#x02009;min. (c) Comparison between the chromatogram of EADL against the chromatograms of eleven pure flavonoids revealed the presence of only rutin (<italic>R</italic><sub>T</sub> = 20.1&#x02009;min) and quercetin (<italic>R</italic><sub>T</sub> = 26.8&#x02009;min) in EADL. Only four pure flavonoid chromatograms were included for comparison with EADL.</p></caption><fig id="F0002a" fig-type="figure" orientation="portrait" position="anchor"><graphic content-type="black-white" xlink:href="IPHB_A_1764058_F0002a_B"/></fig><fig id="F0002b" fig-type="figure" orientation="portrait" position="anchor"><graphic content-type="color" xlink:href="IPHB_A_1764058_F0002b_C"/></fig></fig-group><p>Further analysis of these six peaks based on their UV-vis spectra revealed that they represent bioactive compounds of flavonoids group (<xref rid="t0009" ref-type="table">Table 9</xref>). Peaks 1, 2, 4, 5 and 6, which exerted the UV-vis spectra with two absorbance bands, namely Band A that lies in the 310&#x02013;350&#x02009;nm range and Band B that falls in the 250&#x02013;290&#x02009;nm range, represent bioactive compounds of the flavones type. On the other hand, Peak 3 has the UV-vis spectra with Band A that fall in the range of 350 and 385&#x02009;nm and Band B that lies in the range of 250&#x02013;290&#x02009;nm, represents bioactive compound of the flavonol type.</p><table-wrap id="t0009" orientation="portrait" position="float"><label>Table 9.</label><caption><p>Peak with UV-vis spectra that was a characteristic of a flavonoid-based bioactive compounds.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Peak</th><th align="center">R<sub>T</sub> (min)</th><th align="center">Band A</th><th align="center">Band B</th><th align="center">Types of flavonoids<xref ref-type="table-fn" rid="TF24"><sup>a</sup></xref></th></tr></thead><tbody valign="top"><tr><td align="left">1</td><td align="left">19.3</td><td align="left">347.0</td><td align="left">264.9</td><td align="left">Flavones</td></tr><tr><td align="left">2</td><td align="left">19.9</td><td align="left">313.6</td><td align="left">256.7</td><td align="left">Flavones</td></tr><tr><td align="left">3</td><td align="left">20.8</td><td align="left">352.9</td><td align="left">255.5</td><td align="left">Flavonols</td></tr><tr><td align="left">4</td><td align="left">22.7</td><td align="left">347.0</td><td align="left">264.9</td><td align="left">Flavones</td></tr><tr><td align="left">5</td><td align="left">23.1</td><td align="left">348.2</td><td align="left">255.5</td><td align="left">Flavones</td></tr><tr><td align="left">6</td><td align="left">26.8</td><td align="left">342.2</td><td align="left">263.8</td><td align="left">Flavones</td></tr></tbody></table><table-wrap-foot><fn id="TF24"><p><sup>a</sup>According to the UV-vis spectra range provided by Tsimogiannis et&#x000a0;al. (<xref rid="CIT1002" ref-type="bibr">2007</xref>).</p></fn></table-wrap-foot></table-wrap><p>The chromatograms also clearly revealed that EADL contains a low number of flavonoid-based bioactive compounds as only six major peaks were detected at the wavelength of 366&#x02009;nm. Comparison between the chromatograms of several pure flavonoid-based compounds (i.e., fisetin, quercetin rutin, quercitrin, naringenin, genistein, pinostrobin, flavanone, 4&#x02032;,5,7-trihydroxyflavanone, 2,4,4&#x02032;-trihydroxychalcone, or dihydroquercetin) against the chromatogram of EADL at 366&#x02009;nm revealed that peaks at the retention time (R<sub>T</sub>) of 20.1 and 26.8&#x02009;min represent rutin and quercetin, respectively (<xref ref-type="fig" rid="F0002">Figure 2(c)</xref>).</p></sec></sec><sec id="s0035"><title>Discussion</title><p>Earlier studies on the hepatoprotective potential of <italic>D. linearis</italic> have revealed the ability of the aqueous, chloroform and methanol extracts of the leaves to attenuate PCM- and CCl<sub>4</sub>-induced liver disease. From the observations using the aqueous and chloroform extracts, it is plausible to suggest that the bioactive compounds responsible for the hepatoprotective activity of <italic>D. linearis</italic> consist of polar and non-polar properties, respectively. However, the ability of methanol extract, which contain polar, non-polar and intermediate polar compounds, to attenuate PCM-induced liver disease seems to suggest that the intermediate polar phytoconstituents might also contributed to the observed hepatoprotective activity. To confirm this, EADL was partitioned from MEDL and subjected to the PCM-induced liver injury tests.</p><p>Taking into consideration the involvement of free radical and ROS in the development of PCM-induced liver injury, and the importance of antioxidant restoration to attenuate the PCM-induced hepatotoxicity as described earlier, the first part of the study was carried out to determine the antioxidant and radical scavenging potential of EADL. From the results obtained, EADL was found to contain remarkably higher TPC value, thus, suggesting that it might also possess a high potential to scavenge free radicals and to exert high antioxidant activity. According to Lambert et&#x000a0;al. (<xref rid="CIT0025" ref-type="bibr">2007</xref>), the phenolic compounds found mainly in the plant-based diet are protective against oxidative damage and adverse effects by ROS and free radicals act as both competent radical scavengers and metal chelators without having to depend on the endogenous antioxidant enzymatic defence system generated by human cells. The finding on high TPC value of EADL was also in accordance with a report by Lai and Lim (<xref rid="CIT0024" ref-type="bibr">2011</xref>) on the high TPC content of <italic>D. linearis</italic>. The high TPC value of EADL was similar with the results of phytochemical screening of EADL that revealed the presence of flavonoids and tannins. Sequential analyses carried out on the free radicals scavenging ability of EADL using the DPPH- and SOA-radical scavenging assays confirmed the earlier suggestion that EADL possessed a noteworthy free radical scavenging activity. Based on the reports of the link between TPC value and antioxidant activity (Zheng et&#x000a0;al. <xref rid="CIT0046" ref-type="bibr">2018</xref>), the antioxidant capacity of EADL was measured using the ORAC assay and found to be remarkably higher, which corresponds well with the earlier reports. The role of oxidative stress in development of liver diseases has been well acknowledged (Du et&#x000a0;al. <xref rid="CIT0007" ref-type="bibr">2016</xref>) and, therefore, it is postulated that any compounds with antioxidative potential are also believed to possess protective effect against liver damage. Based on this postulation, it is reasonable to suggest that the EADL might also possessed the ability to exert the hepatoprotective activity.</p><p>Hepatic inflammation is a common trigger of liver disease, and is considered the main driver of hepatic tissue damage. Pu et&#x000a0;al. (<xref rid="CIT0034" ref-type="bibr">2016</xref>) have demonstrated the critical role of 5&#x02010;LOX activity in PCM&#x02010;induced liver injury by regulating PCM metabolism and oxidative stress. On the other hand, although allopurinol, an inhibitor of XO, attenuate oxidative stress and liver injury in PCM intoxicated mice, further investigation has disputed the participation of XO in the pathophysiology of PCM-induced hepatotoxicity (Williams et al. <xref rid="CIT0041" ref-type="bibr">2014</xref>). According to Williams et al. (<xref rid="CIT0041" ref-type="bibr">2014</xref>), allopurinol-induced liver protection occurs via complicated mechanisms that do not simply involve the ability to inhibit XO or scavenge reactive oxygen, and these might include the adjustment of the intracellular signalling pathways or the up-regulation of the cytoprotective gene expression. In the second part of this study, the ability of EADL to modulate inflammatory process via the LOX or XO pathways was determined using the <italic>in&#x000a0;vitro</italic> models. EADL was found to show a very low inhibitory effect against LOX- and XO-mediated inflammatory activity. Hence, it is plausible to suggest that the EADL-triggered attenuation of PCM-induced liver intoxication is not achieved via the inhibition of the LOX- or XO-mediated inflammation. Concurrently, the lack of anti-inflammatory activity via the LOX- and XO-mediated pathway seen with EADL was also reported for MEDL (Zakaria et&#x000a0;al. <xref rid="CIT0044" ref-type="bibr">2017</xref>).</p><p>In the hepatoprotective study, silymarin, a plant secondary metabolite, was chosen as the positive control drug based on previous report that it has been used worldwide for many years as a complementary alternative medicine because of the beneficial effects associated with the treatment of hepatic diseases (Vargas-Mendoza et&#x000a0;al. <xref rid="CIT0040" ref-type="bibr">2014</xref>). This could be associated mainly with silymarin ability to exert antioxidant and anti-inflammatory activities in addition to its anti-fibrotic activity. Interestingly, plant extracts, such as MEDL, have also been reported to exert these activities (Mamat et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2013</xref>; Zakaria et&#x000a0;al. <xref rid="CIT0044" ref-type="bibr">2017</xref>). The hepatoprotective and antioxidant activities of silymarin are caused by its ability to inhibit free radicals that are produced from the metabolism of toxic substances such as PCM, carbon tetrachloride or ethanol. It was also reported that silymarin reversed the PCM-induced liver intoxication by causing significant reduction in the levels of ALT and AST, decrease in the level of MDA while causing significant increase in the activity of SOD and CAT (Kasi Reddy et&#x000a0;al. <xref rid="CIT0035" ref-type="bibr">2017</xref>). These biochemical parameter findings were further supported by the histopathological examination. Concurrently, MEDL was also previously demonstrated to exert the similar effects. Furthermore, silymarin was also reported to attenuate PCM-induced liver intoxication via its anti-inflammatory potential, an activity that was also reported for MEDL (Zakaria et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2020</xref>) and further supported by the absence of inflammation in the PCM-intoxicated liver tissue that was pre-treated with MEDL following the present qualitative histopathological scoring (Zakaria et&#x000a0;al. <xref rid="CIT0044" ref-type="bibr">2017</xref>). Since EADL triggers hepatoprotective activity via an similar mechanisms of action that was comparable to silymarin, it is plausible to suggest that <italic>D. linearis</italic> could be potentially developed as an alternative hepatoprotective agent for future human consumption. The fact that silymarin derived from <italic>Silybum marianum</italic> (L.) Gaertn. (Asteraceae), a plant popularly known as milk thistle and found in European and some Asian countries, except Malaysia, plausibly suggests that the former is an expensive source of hepatoprotective agent. Thus, it is beneficial to promote the usage and further develop <italic>D. linearis</italic>, which is wildly grown particularly in Malaysia, as a replacement of hepatoprotective agent that is cheaper than silymarin for use, particularly, in Southeast Asian countries. However, to achieve this, further clinical study needs to be carried out to prove that the product of <italic>D. linearis</italic> is an effective hepatoprotective agent that is safe for human consumption.</p><p>Although EADL exerts a weak anti-inflammatory activity via the LOX- and XO-mediated pathways, the significant antioxidant and radical scavenging effects observed seems to suggest that EADL still possesses a capability to exert hepatoprotective activity. Attempts to determine the hepatoprotective potential of EADL against PCM-induced intoxication in rats revealed the ability of EADL to reverse PCM toxic effect on the liver of rats. This claim was based on several observations made during the hepatoprotective study whereby EADL significantly: i) reduced the serum liver enzymes (i.e., ALT and AST) and TB levels; ii) reduced the LW and LW/BW ratio values; which were all found to increase significantly following the intoxication with PCM. The abnormalities induced by PCM intoxication was reversed following the pre-treatment with EADL signifying the partition ability to prevent intracellular enzymes leakage by stabilising or restoring the membrane activity. Moreover, EADL ability to attenuate PCM-induced toxicity in rats is believed to involve the activation of endogenous antioxidant enzymes defence system and attenuation of the lipid peroxidation mechanism based on the observations that EADL: i) increased the activity of liver antioxidant enzymes, namely SOD and CAT, and; ii) reduced the level of MDA, an end product of lipid peroxidation, respectively. The ability of EADL to enhance the activity of SOD and CAT help to neutralise the effect of NAPQ1 and ROS leading to attenuation of liver damage. Interestingly, it was also claimed that natural antioxidants, a characteristic exhibited by EADL as described earlier, strengthen the defence provided by endogenous antioxidant enzymes (i.e., SOD and CAT) from ROS, hence, restore the optimal balance by neutralising reactive species (Azab and Albasha <xref rid="CIT1001" ref-type="bibr">2018</xref>). Interestingly, all of these findings, which lead to a conclusion that EADL possesses the hepatoprotective activity, were further supported by the histopathological findings. From the histopathological analysis, EADL was found to improve the liver cell architectures by reducing the severity of necrosis, promotion of cellular boundaries and protection against broad lymphocytes infiltration. Based on the histopathological findings (<xref ref-type="fig" rid="F0001">Figure 1</xref>) and scoring (<xref rid="t0007" ref-type="table">Table 7</xref>), it is worth mentioning that the hepatoprotective effect of EADL occurs in a dose-independent manner. The ability of 50&#x02009;mg/kg EADL to exert mild necrosis without inflammation, 250&#x02009;mg/kg EADL to show moderate necrosis and mild inflammation and 500&#x02009;mg/kg EADL to prevent necrosis and inflammation when compared to the PCM-induced hepatotoxic group suggests the fraction&#x02019;s dose-independent response. The dose-independent response exerted by EADL could be explained by a phenomenon known as &#x02018;therapeutic window&#x02019; wherein certain drugs can only produce suboptimal beneficial effects or even a decline in effects when the dose used was below or above the narrow therapeutic range (Tripathi <xref rid="CIT0039" ref-type="bibr">2001</xref>).</p><p>Other than the role of exogenous and endogenous antioxidant pathways, the ability of EADL to exert hepatoprotective activity could also be linked to its phytoconstituents. Qualitative phytochemicals screening of EADL revealed the presence of at least saponins, flavonoids, tannins and polyphenolic compounds. Numerous studies have reported on the antioxidant potential of these classes of bioactive compounds (Chen et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2014</xref>; Nile et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2018</xref>; Chai et&#x000a0;al. <xref rid="CIT0005" ref-type="bibr">2019</xref>; Kouka et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>). Moreover, saponins, flavonoids and polyphenolic compounds have also been reported to exert hepatoprotective activity against PCM-induced intoxication (Kelava and Cavar <xref rid="CIT0020" ref-type="bibr">2014</xref>; Baali et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2016</xref>; Huang et&#x000a0;al. <xref rid="CIT0012" ref-type="bibr">2017</xref>). Despite no reports on its potential to attenuate PCM-induced liver injury, tannins have also been reported to exert hepatoprotective activity against other inducers (Sobeh et&#x000a0;al. <xref rid="CIT0038" ref-type="bibr">2017</xref>). The ability of different classes of bioactive compounds cited above to exert antioxidant and hepatoprotective activities supported the observed antioxidant and heaptoprotective activities of EADL. It is also believed that the hepatoprotective activity of EADL resulted from the synergistic action of different classes of bioactive compounds.</p><p>Further analysis of EADL using HPLC revealed the presence of six major peaks at 366&#x02009;nm, which after the UV-vis spectra analysis revealed the presence of flavonoid-based bioactive compounds. Based on the range of absorbance for Band A and Band B that was characteristics of flavonoids, Peaks 1, 2, 4, 5 and 6 were detected to represent bioactive compounds of the flavones type (Band A falls in the range of 310&#x02013;350&#x02009;nm; Band B falls within the range of 250&#x02013;290&#x02009;nm) while Peak 3 was detected to represent bioactive compounds of the flavonol type (Band A falls within the range of 350&#x02013;385&#x02009;nm; Band B falls within the range of 250&#x02013;290&#x02009;nm). Further comparison of the chromatogram that belongs to EADL against the respective chromatogram of several pure flavonoids, namely fisetin, quercetin rutin, quercitrin, naringenin, genistein, pinostrobin, flavanone, 4&#x02032;,5,7-trihydroxyflavanone, 2,4,4&#x02032;-trihydroxychalcone, or dihydroquercetin, revealed that only Peak 2 and Peak 6 fall within the exact retention times recorded for rutin and quercetin, respectively. In accordance with this finding, rutin and quercetin have earlier been reported to exert antioxidant (Habtemariam and Belai <xref rid="CIT0009" ref-type="bibr">2018</xref>) as well as hepatoprotective (Janbaz et&#x000a0;al. <xref rid="CIT0018" ref-type="bibr">2002</xref>; Barros et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2017</xref>) activities.</p></sec><sec id="s0036"><title>Conclusions</title><p>EADL exerted hepatoprotective activity against PCM intoxication is attributed to its high antioxidant capacity and its ability to scavenge free radicals. In addition, EADL also improves the endogenous antioxidant enzymatic defence system destroyed by PCM overdose, which could be associated with the presence of saponins, tannins, flavonoid-based glycosides and polyphenolic compounds.</p></sec></body><back><sec><title>Acknowledgements</title><p>The authors thank the Faculty of Medicine and Health Sciences, UPM, Malaysia, for providing the facilities to carry out the experiments.</p></sec><sec id="s0037"><title>Disclosure statement</title><p>The authors declare that there is no conflict interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asrani</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Devarbhavi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kamath</surname><given-names>PS</given-names></name></person-group>
<year>2019</year>
<article-title>Burden of liver diseases in the world</article-title>. <source>J Hepatol</source>. <volume>70</volume>(<issue>1</issue>):<fpage>151</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">30266282</pub-id></mixed-citation></ref><ref id="CIT1001"><mixed-citation publication-type="journal">Azab AE, Albasha MO. <year>2018</year>. Hepatoprotective effect of some medicinal plants and herbs against hepatic disorders induced by hepatotoxic agents. J Biotechnol Bioeng. 2(1):8&#x02013;23.</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azhar-Ul-Haq Malik</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Anis</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Nawaz</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Choudhary</surname><given-names>MI</given-names></name></person-group>
<year>2004</year>
<article-title>Enzyme inhibiting lignans from <italic>Vitex negundo</italic></article-title>. <source>Chem Pharm Bull</source>. <volume>52</volume>:<fpage>1269</fpage>&#x02013;<lpage>1272</lpage>.<pub-id pub-id-type="pmid">15520511</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baali</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Belloum</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Baali</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chabi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pessemesse</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fouret</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ameddah</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Benayache</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Benayache</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Feillet-Coudray</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2016</year>
<article-title>Protective activity of total polyphenols from <italic>Genista quadriflora</italic> Munby and <italic>Teucrium polium geyrii</italic> Maire in acetaminophen-induced hepatotoxicity in rats</article-title>. <source>Nutrients</source>. <volume>8</volume>(<issue>4</issue>):<fpage>193</fpage>.<pub-id pub-id-type="pmid">27043622</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barros</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>da Silva</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Silva Goncalves</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Pagnan</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Arco-e-Flexa</surname><given-names>L</given-names></name></person-group>
<year>2017</year>
<article-title>Hepatoprotective effect of quercetin pretreatment against paracetamol-induced liver damage and partial hepatectomy in rats</article-title>. <source>Braz Arch Biol Technol</source>. <volume>60</volume>:<fpage>e16160138</fpage>.</mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chai</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>QM</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XY</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Ou-Yang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>YY</given-names></name></person-group>
<year>2019</year>
<article-title>Anti-melanogenesis properties of condensed tannins from <italic>Vigna angularis</italic> seeds with potent antioxidant and DNA damage protection activities</article-title>. <source>Food Funct</source>. <volume>10</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">30565612</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name></person-group>
<year>2014</year>
<article-title>Antioxidant activities of saponins extracted from <italic>Radix Trichosanthis</italic>: an <italic>in&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> evaluation</article-title>. <source>BMC Complement Altern Med</source>. <volume>14</volume>(<issue>1</issue>):<fpage>86</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">24597831</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ramachandran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name></person-group>
<year>2016</year>
<article-title>Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential</article-title>. <source>Redox Biol</source>. <volume>10</volume>(<issue>1</issue>):<fpage>148</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="pmid">27744120</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Beshbishy</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Mohamadin</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Nagy</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Abdel-Naim</surname><given-names>AB</given-names></name></person-group>
<year>2010</year>
<article-title>Amelioration of tamoxifen-induced liver injury in rats by grape seed extract, black seed extract and curcumin</article-title>. <source>Indian J Exp Biol</source>. <volume>48</volume>(<issue>3</issue>):<fpage>280</fpage>&#x02013;<lpage>288</lpage>.<pub-id pub-id-type="pmid">21046982</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habtemariam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Belai</surname><given-names>A</given-names></name></person-group>
<year>2018</year>
<article-title>Natural therapies of the inflammatory bowel disease: the case of rutin and its aglycone, quercetin</article-title>. <source>Mini Rev Med Chem</source>. <volume>18</volume>(<issue>3</issue>):<fpage>234</fpage>&#x02013;<lpage>243</lpage>.<pub-id pub-id-type="pmid">28117024</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hinson</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>James</surname><given-names>LP</given-names></name></person-group>
<year>2010</year>
<article-title>Mechanisms of acetaminophen-induced liver necrosis</article-title>. <source>Handb Exp Pharmacol</source>. <volume>196</volume>:<fpage>369</fpage>&#x02013;<lpage>405</lpage>.</mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ou</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hampsch-Woodill</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Flanagan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Prior</surname><given-names>RL</given-names></name></person-group>
<year>2002</year>
<article-title>High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format</article-title>. <source>J Agric Food Chem</source>. <volume>50</volume>(<issue>16</issue>):<fpage>4437</fpage>&#x02013;<lpage>4444</lpage>.<pub-id pub-id-type="pmid">12137457</pub-id></mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Protective effect of flavonoids from <italic>Ziziphus jujuba</italic> cv. Jinsixiaozao against acetaminophen-induced liver injury by inhibiting oxidative stress and inflammation in mice</article-title>. <source>Molecules</source>. <volume>22</volume>(<issue>10</issue>):<fpage>1781</fpage>.</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikhiri</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Boureima</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dicko</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Koulodo</surname><given-names>D</given-names></name></person-group>
<year>1992</year>
<article-title>Chemical screening of medicinal plants used in the traditional pharmacopoeia of Niger</article-title>. <source>Int J Pharmacog</source>. <volume>30</volume>(<issue>4</issue>):<fpage>251</fpage>&#x02013;<lpage>262</lpage>.</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ilyas</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Katare</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Aeri</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Naseef</surname><given-names>PP</given-names></name></person-group>
<year>2016</year>
<article-title>A review on hepatoprotective and immunomodulatory herbal plants</article-title>. <source>Phcog Rev</source>. <volume>10</volume>(<issue>19</issue>):<fpage>66</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">27041876</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Shamsahal Din</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Zabidi</surname><given-names>ZW</given-names></name>, <name name-style="western"><surname>Zainulddin</surname><given-names>WN</given-names></name>, <name name-style="western"><surname>Kamisan</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Desa</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2014</year>
<article-title>Effect of aqueous extract of <italic>Dicranopteris linearis</italic> leaves against paracetamol and carbon tetrachloride-induced liver toxicity in rats</article-title>. <source>Pak J Pharm Sci</source>. <volume>27</volume>:<fpage>831</fpage>&#x02013;<lpage>835</lpage>.<pub-id pub-id-type="pmid">25015448</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail Suhaimy</surname><given-names>NW</given-names></name>, <name name-style="western"><surname>Noor Azmi</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Md. Tohid</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Cheema</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Teh</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Salleh</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2017</year>
<article-title>Semipurified ethyl acetate partition of methanolic extract of <italic>Melastoma malabathricum</italic> leaves exerts gastroprotective activity partly via its antioxidant-antisecretory-anti-inflammatory action and synergistic action of several flavonoid-based compounds</article-title>. <source>Oxid Med Cell Longev</source>. <volume>2017</volume>:<fpage>6542631</fpage>.<pub-id pub-id-type="pmid">28168011</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jafari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Salehi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zardooz</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rostamkhani</surname><given-names>F</given-names></name></person-group>
<year>2014</year>
<article-title>Response of liver antioxidant defense system to acute and chronic physical and psychological stresses in male rats</article-title>. <source>Excli J</source>. <volume>13</volume>(<issue>1</issue>):<fpage>161</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">26417250</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janbaz</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Saeed</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Gilani</surname><given-names>AH</given-names></name></person-group>
<year>2002</year>
<article-title>Protective effect of rutin on paracetamol- and CCl<sub>4</sub>-induced hepatotoxicity in rodents</article-title>. <source>Fitoterapia</source>. <volume>73</volume>(<issue>7&#x02013;8</issue>):<fpage>557</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">12490212</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamisan</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Kamarolzaman</surname><given-names>MFF</given-names></name>, <name name-style="western"><surname>Suhaili</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ching</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Teh</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Salleh</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Abdullah</surname><given-names>MNH</given-names></name></person-group>
<year>2014</year>
<article-title>Effect of methanol extract of <italic>Dicranopteris linearis</italic> against carbon tetrachloride-induced acute liver injury in rats</article-title>. <source>BMC Complement Altern Med</source>. <volume>14</volume>(<issue>1</issue>):<fpage>123</fpage>&#x02013;<lpage>132</lpage>.<pub-id pub-id-type="pmid">24708543</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelava</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cavar</surname><given-names>I</given-names></name></person-group>
<year>2014</year>
<article-title>Hepatoprotective action of <italic>Panaxatriol saponins</italic> against acetaminophen-induced liver injury: what is the mechanism?</article-title>
<source>Liver Int</source>. <volume>34</volume>(<issue>4</issue>):<fpage>644</fpage>&#x02013;<lpage>645</lpage>.<pub-id pub-id-type="pmid">24314316</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kirchain</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>RE</given-names></name></person-group>
<year>2014</year>
<chapter-title>eChapter 17. Drug-induced liver disease</chapter-title> In: <person-group person-group-type="editor"><name name-style="western"><surname>DiPiro</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Talbert</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Matzke</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Posey</surname><given-names>L</given-names></name></person-group>, editors. <source>Pharmacotherapy: a pathophysiologic approach</source>. <edition>9th ed.</edition>
<publisher-loc>New York (NY)</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name> [accessed 2019 Apr 12]. <ext-link ext-link-type="uri" xlink:href="http://accesspharmacy.mhmedical.com/content.aspx?bookid=689&#x00026;sectionid=48811442">http://accesspharmacy.mhmedical.com/content.aspx?bookid=689&#x00026;sectionid=48811442</ext-link>.</mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kisaoglu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ozogul</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Turan</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Yilmaz</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Demiryilmaz</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Atamanalp</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Bakan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Suleyman</surname><given-names>H</given-names></name></person-group>
<year>2014</year>
<article-title>Damage induced by paracetamol compared with <italic>N</italic>-acetylcysteine</article-title>. <source>J Chin Med Assoc</source>. <volume>77</volume>(<issue>9</issue>):<fpage>463</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">25028290</pub-id></mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kouka</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tsakiri</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Tzortzi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dimopoulou</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sarikaki</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stathopoulos</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Veskoukis</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Halabalaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Skaltsounis</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Kouretas</surname><given-names>D</given-names></name></person-group>
<year>2019</year>
<article-title>The polyphenolic composition of extracts derived from different Greek extra virgin olive oils is correlated with their antioxidant potency</article-title>. <source>Oxid Med Cell Longev</source>. <volume>2019</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>YY</given-names></name></person-group>
<year>2011</year>
<article-title>Evaluation of antioxidant activities of the methanolic extracts of selected ferns in Malaysia</article-title>. <source>Int J Environ Sci Technol</source>. <volume>2</volume>:<fpage>442</fpage>&#x02013;<lpage>447</lpage>.</mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Sang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CS</given-names></name></person-group>
<year>2007</year>
<article-title>Possible controversy over dietary polyphenols: benefits vs risks</article-title>. <source>Chem Res Toxicol</source>. <volume>20</volume>(<issue>4</issue>):<fpage>583</fpage>&#x02013;<lpage>585</lpage>.<pub-id pub-id-type="pmid">17362033</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>ZJ</given-names></name>, <name name-style="western"><surname>Lao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name></person-group>
<year>2015</year>
<article-title>The role of oxidative stress and antioxidants in liver diseases</article-title>. <source>Int J Mol Sci</source>. <volume>16</volume>(<issue>11</issue>):<fpage>26087</fpage>&#x02013;<lpage>26124</lpage>.<pub-id pub-id-type="pmid">26540040</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ooi</surname><given-names>VEC</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>ST</given-names></name></person-group>
<year>1997</year>
<article-title>Free radical scavenging activities of mushroom polysaccharide extracts</article-title>. <source>Life Sci</source>. <volume>60</volume>(<issue>10</issue>):<fpage>763</fpage>&#x02013;<lpage>771</lpage>.<pub-id pub-id-type="pmid">9064481</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowry</surname><given-names>OH</given-names></name>, <name name-style="western"><surname>Rosebrough</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Farr</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Randall</surname><given-names>RJ</given-names></name></person-group>
<year>1951</year>
<article-title>Protein measurement with the Folin phenol reagent</article-title>. <source>J Biol Chem</source>. <volume>193</volume>(<issue>1</issue>):<fpage>265</fpage>&#x02013;<lpage>275</lpage>.<pub-id pub-id-type="pmid">14907713</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Kamisan</surname><given-names>FHW</given-names></name>, <name name-style="western"><surname>Zainulddin</surname><given-names>WN</given-names></name>, <name name-style="western"><surname>Ismail</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Shamsahal Din</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zabidi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Arifah</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2013</year>
<article-title>Effect of methanol extract of <italic>Dicranopteris linearis</italic> leaves against paracetamol- and CCl<sub>4</sub>-induced liver toxicity in rats</article-title>. <source>J Med Plant Res</source>. <volume>7</volume>:<fpage>1305</fpage>&#x02013;<lpage>1309</lpage>.</mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGaw</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Bagla</surname><given-names>VP</given-names></name>, <name name-style="western"><surname>Steenkamp</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Fouche</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Olivier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Eloff</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Myer</surname><given-names>MS</given-names></name></person-group>
<year>2013</year>
<article-title>Antifungal and antibacterial activity and chemical composition of polar and non-polar extracts of <italic>Athrixia phylicoides</italic> determined using bioautography and HPLC</article-title>. <source>BMC Complement Altern Med</source>. <volume>13</volume>(<issue>1</issue>):<fpage>356</fpage>&#x02013;<lpage>366</lpage>.<pub-id pub-id-type="pmid">24330447</pub-id></mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nile</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Keum</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Nile</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Jalde</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>RV</given-names></name></person-group>
<year>2018</year>
<article-title>Antioxidant, anti-inflammatory, and enzyme inhibitory activity of natural plant flavonoids and their synthesized derivatives</article-title>. <source>J Biochem Mol Toxicol</source>. <volume>32</volume>(<issue>1</issue>):<fpage>e22002</fpage>.</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nithianantham</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Shyamala</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Latha</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Jothy</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Sasidharan</surname><given-names>S</given-names></name></person-group>
<year>2011</year>
<article-title>Hepatoprotective potential of <italic>Clitoria ternatea</italic> leaf extract against paracetamol induced damage in mice</article-title>. <source>Molecules</source>. <volume>16</volume>(<issue>12</issue>):<fpage>10134</fpage>&#x02013;<lpage>10145</lpage>.<pub-id pub-id-type="pmid">22146374</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noro</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Miyase</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kuroyanagi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fukushima</surname><given-names>S</given-names></name></person-group>
<year>1983</year>
<article-title>Monoamine oxidase inhibitor from the rhizomes of <italic>Kaempferia galanga</italic> L</article-title>. <source>Chem Pharm Bull</source>. <volume>31</volume>(<issue>8</issue>):<fpage>2708</fpage>&#x02013;<lpage>2711</lpage>.<pub-id pub-id-type="pmid">6652816</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Kuang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2016</year>
<article-title>Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity</article-title>. <source>Brit J Pharmacol</source>. <volume>173</volume>(<issue>1</issue>):<fpage>66</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">26398229</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reddy</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Reddy</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Madhuri</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Boobalan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Reddy</surname><given-names>MA</given-names></name></person-group>
<year>2017</year>
<article-title>Protective effect of rutin in comparison to silymarin against induced hepatotoxicity in rats</article-title>. <source>Vet World</source>. <volume>10</volume>(<issue>1</issue>):<fpage>74</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">28246450</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saleem</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Iftikhar</surname><given-names>H</given-names></name></person-group>
<year>2019</year>
<article-title>A rare case of acetaminophen toxicity leading to severe kidney injury</article-title>. <source>Cureus</source>. <volume>11</volume>(<issue>6</issue>):<fpage>e5003</fpage>.<pub-id pub-id-type="pmid">31497434</pub-id></mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shamsahal Din</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Ismail NA</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zainulddin</surname><given-names>WN</given-names></name>, <name name-style="western"><surname>Zabidi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kamisan</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Othman</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Suhaili</surname><given-names>Z</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2012</year>
<article-title>Effect of chloroform extract of <italic>Dicranopteris linearis</italic> leaves against paracetamol- and CCl<sub>4</sub>-induced liver toxicity in rats</article-title>. <source>Tang</source>. <volume>2</volume>:<fpage>e34</fpage>.</mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sobeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mahmoud</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Abdelfattah</surname><given-names>MAO</given-names></name>, <name name-style="western"><surname>El-Beshbishy</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>El-Shazly</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Wink</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Hepatoprotective and hypoglycemic effects of a tannin rich extract from <italic>Ximenia americana</italic> var. <italic>caffra</italic> root</article-title>. <source>Phytomedicine</source>. <volume>33</volume>(<issue>1</issue>):<fpage>36</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">28887918</pub-id></mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Tripathi</surname><given-names>KD</given-names></name></person-group>
<year>2001</year>
<source>Essentials of medical pharmacology</source>. <edition>4th ed</edition>
<publisher-loc>New Delhi</publisher-loc>
<publisher-name>Jaypee Brothers Medical Publishers</publisher-name>; p. <fpage>52</fpage>&#x02013;<lpage>53</lpage>.</mixed-citation></ref><ref id="CIT1002"><mixed-citation publication-type="book">Tsimogiannis D, Samiotaki M, Panayotou G, Oreopoulou V. <year>2007</year>. Characterization of flavonoid subgroups and hydroxy substitution by HPLC MS/MS. Molecules. 12:593-606.</mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vargas-Mendoza</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Madrigal-Santill&#x000e1;n</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Morales-Gonz&#x000e1;lez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Esquivel-Soto</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Esquivel-Chirino</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Garc&#x000ed;a-Luna</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gonz&#x000e1;lez-Rubio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gayosso-de-Lucio</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Morales-Gonz&#x000e1;lez</surname><given-names>JA</given-names></name></person-group>
<year>2014</year>
<article-title>Hepatoprotective effect of silymarin</article-title>. <source>World J Hepatol</source>. <volume>6</volume>(<issue>3</issue>):<fpage>144</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">24672644</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>McGill</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Lebofsky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bajt</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name></person-group>
<year>2014</year>
<article-title>Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning</article-title>. <source>Toxicol Appl Pharmacol</source>. <volume>274</volume>(<issue>3</issue>):<fpage>417</fpage>&#x02013;<lpage>424</lpage>.<pub-id pub-id-type="pmid">24345528</pub-id></mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Kamarolzaman</surname><given-names>MFF</given-names></name>, <name name-style="western"><surname>Seyedan</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Jakius</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Mahmood</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Shahril</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Suhaili</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Susanti</surname><given-names>D</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2013</year>
<article-title>Hepatoprotective activity of methanolic extract of <italic>Bauhinia purpurea</italic> leaves against paracetamol-induced hepatic damage in rats</article-title>. <source>Evid-Based Complement Altern Med</source>. <volume>2013</volume>:<fpage>636580</fpage>.</mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Kamisan</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Mahmood</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Othman</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Abdul Hamid</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Abdullah</surname><given-names>MNH</given-names></name></person-group>
<year>2017</year>
<article-title>Methanol extract of <italic>Dicranopteris linearis</italic> L. leaves impedes acetaminophen-induced liver intoxication partly by enhancing the endogenous antioxidant system</article-title>. <source>BMC Complement Altern Med</source>. <volume>17</volume>(<issue>1</issue>):<fpage>271</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">28521788</pub-id></mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Roosli</surname><given-names>RAJ</given-names></name>, <name name-style="western"><surname>Marmaya</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Basir</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Somchit</surname><given-names>MN</given-names></name></person-group>
<year>2020</year>
<article-title>Methanol extract of <italic>Dicranopteris linearis</italic> leaves attenuate pain via the modulation of opioid/NO-mediated pathway</article-title>. <source>Biomolecules</source>. <volume>10</volume>(<issue>2</issue>):<fpage>280</fpage>.</mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Maninder</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>B</given-names></name></person-group>
<year>2018</year>
<article-title>Total phenolics and antioxidants profiles of commonly consumed edible flowers in China</article-title>. <source>Int J Food Prop</source>. <volume>21</volume>(<issue>1</issue>):<fpage>1524</fpage>&#x02013;<lpage>1540</lpage>.</mixed-citation></ref></ref-list></back></article>